Merck KGaA (OTCMKTS:MKKGY) Sees Large Decline in Short Interest

Merck KGaA (OTCMKTS:MKKGY) was the recipient of a significant decrease in short interest in the month of January. As of January 30th, there was short interest totaling 120,341 shares, a decrease of 34.8% from the January 15th total of 184,605 shares. Based on an average daily trading volume, of 138,732 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.0% of the company’s shares are short sold. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 138,732 shares, the days-to-cover ratio is currently 0.9 days.

Merck KGaA Stock Up 1.5%

OTCMKTS:MKKGY opened at $30.27 on Friday. Merck KGaA has a 1 year low of $24.32 and a 1 year high of $31.00. The stock has a 50-day moving average price of $29.19 and a two-hundred day moving average price of $27.22. The stock has a market cap of $19.56 billion, a price-to-earnings ratio of 12.06, a PEG ratio of 6.04 and a beta of 0.96. The company has a current ratio of 1.49, a quick ratio of 0.97 and a debt-to-equity ratio of 0.36.

Merck KGaA (OTCMKTS:MKKGY) last released its quarterly earnings data on Thursday, November 13th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.27. Merck KGaA had a return on equity of 10.07% and a net margin of 13.92%.The business had revenue of $6.17 billion for the quarter, compared to analysts’ expectations of $6.08 billion. As a group, equities analysts expect that Merck KGaA will post 1.87 earnings per share for the current year.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft lowered Merck KGaA from a “buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.